Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

10.69
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
8.75
Today|||52-Week Range
15.45
+2.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues22.5M14.6M172.3M149.8M
 
 
 
 
 
Cost of Goods Sold1.3M975.9K10.3M12.6M
 
 
 
 
 
Depreciation And Amortization3.1M13.9M13.1M14.4M
 
 
 
 
 
 
Operating ExpensesGross Income18.1M-351.6K148.9M122.8M
 
 
 
 
 
General Expenses45.8M37.9M47.1M78.6M
 
 
 
 
 
Other Operating Expenses9.6M22.0M0.000.00
 
 
 
Research And Development32.5M22.5M25.5M34.5M
 
 
 
 
 
Total Operating Expenses59.8M74.8M70.4M105.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-37.3M-60.2M101.9M44.2M
 
 
 
 
 
Extraordinary Charge-28.2M-59.6M-30.8M-49.1M
 
 
 
 
 
Interest Expense On Debt4.6M9.1M1.4M960.2K
 
 
 
 
 
Other Expenses285.2K11.7M5.7M-5.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-69.5M-116.4M78.0M-9.7M
 
 
 
 
 
Income Taxes-26.6M-28.8M-37.5M-31.5M
 
 
 
 
 
Discontinued Operations0.004.0M0.000.00
 
 
Net Income-43.0M-83.6M40.4M-41.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.5M36.2M40.6M41.2M
 
 
 
 
 
Shares To Calculate EPS Diluted25.5M36.2M43.6M41.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.69-$2.30$0.99-$1.00
 
 
 
 
 
EPS Diluted-$1.69-$2.30$0.93-$1.00